Latest Clinical Research Associate Jobs

Head, Oncology Clinical Development - ADCs

Leads end-to-end clinical development of an antibody-drug conjugate (ADC) oncology asset across multiple tumor types, from first-in-human through registrational trials and launch. Responsible for shaping clinical strategy, overseeing global trials, engaging with regulatory authorities, and integrating translational research and innovative approaches like AI/ML and real-world evidence. Acts as senior clinical representative in governance forums and external scientific engagements.

GSK Stevenage, United Kingdom US$242,250 – US$403,750 pa

Head, Oncology Clinical Development - ADCs

Lead the clinical development strategy for antibody-drug conjugates (ADCs) across multiple tumor types, from early-phase through registrational trials and market launch. Drive integrated clinical and translational research, represent the asset at key governance forums, and shape portfolio-level decision-making in oncology. Work across global cross-functional teams to advance innovative therapies within a matrixed biopharma environment.

GSK United States £242,250 – £403,750 pa

Interventional Study Scientist Medical Director

Lead the scientific design and execution of interventional clinical studies within Medical Affairs, ensuring alignment with strategic evidence plans and regulatory standards. Provide medical governance, oversee study protocols and data interpretation, and collaborate with cross-functional teams and external stakeholders. Engage with investigators and thought leaders to enhance study design and contribute to publications and regulatory submissions.

GSK £187,275 – £312,125 pa

Vice President - Oncology Clinical Development, Disease Area Head- Hematology

This role involves leading the clinical development strategy for GSK's Hematology portfolio, from early-phase studies to market launch. Responsibilities include shaping scientific and clinical strategies, managing cross-functional teams, and ensuring regulatory compliance and market readiness for innovative oncology therapies.

GSK Stevenage, United Kingdom

Vice President - Oncology Clinical Development, Disease Area Head- Hematology

This role involves leading the clinical development strategy for GSK's hematology portfolio, from early-phase studies to market launch. Responsibilities include shaping scientific approaches, managing cross-functional teams, and ensuring regulatory compliance. The role requires deep expertise in hematology/oncology and a proven track record in clinical trial design and execution.

GSK United States

Hybrid Permanent

Vice President - Oncology Clinical Development, Disease Area Head- Hematology

This role involves leading the clinical development strategy for GSK's Hematology portfolio, from early-phase studies to market launch. Responsibilities include shaping scientific approaches, managing cross-functional teams, and ensuring regulatory compliance. The role requires extensive experience in oncology clinical development and leadership.

GSK

Vice President - Oncology Clinical Development, Disease Area Head- Hematology

This role involves leading the clinical development strategy for GSK's Hematology portfolio, from early-phase studies to market launch. Responsibilities include shaping scientific approaches, managing cross-functional teams, and ensuring regulatory compliance. The role emphasizes innovation, collaboration, and patient-centric focus.

GSK

Vice President - Oncology Clinical Development, Disease Area Head- Hematology

This role involves leading the clinical development strategy for GSK's hematology portfolio, from early-phase studies to market launch. Responsibilities include shaping scientific approaches, managing cross-functional teams, and ensuring regulatory compliance. The role emphasizes innovation, patient-centric focus, and strong leadership.

GSK

Director, AI/ML MIDD Oncology Clinical Pharmacology, Modeling and Simulation

Lead and execute model-informed drug development strategies in oncology, applying advanced pharmacometric and AI/ML techniques to optimize clinical trial design, dose selection, and regulatory submissions. Drive innovation in exposure-response analysis, population PK/PD, and quantitative systems pharmacology within a cross-functional R&D environment.

GSK Stevenage, United Kingdom £119,250 – £198,750 pa

Director, AI/ML MIDD Oncology Clinical Pharmacology, Modeling and Simulation

Lead and execute model-informed drug development strategies in oncology, applying advanced pharmacometric and AI/ML techniques to optimize dose selection, trial design, and regulatory submissions. Work across multidisciplinary teams to drive quantitative decision-making in clinical pharmacology and contribute to the development of innovative cancer therapies.

GSK United States £188,100 – £313,500 pa

Director, AI/ML MIDD Oncology Clinical Pharmacology, Modeling and Simulation

Lead and execute model-informed drug development strategies in oncology, applying advanced pharmacometric and AI/ML techniques to optimize clinical trial design, dose selection, and regulatory submissions. Drive innovation in quantitative clinical pharmacology across the R&D pipeline, from early development through lifecycle management, within a multidisciplinary translational medicine team.

GSK £119,250 – £198,750 pa

Director, AI/ML MIDD Oncology Clinical Pharmacology, Modeling and Simulation

Lead and deliver model-informed drug development (MIDD) strategies in oncology, applying advanced pharmacometric and AI/ML techniques to optimize clinical trial design, dose selection, and regulatory submissions. Work across multidisciplinary teams to advance GSK’s oncology pipeline using quantitative approaches including exposure-response modeling, disease progression models, and simulation-based trial design. Drive innovation through external collaborations, publications, and adoption of cutting-edge methodologies in clinical pharmacology.

GSK

Director, AI/ML MIDD Oncology Clinical Pharmacology, Modeling and Simulation

Lead and execute model-based drug development strategies in oncology, applying advanced pharmacometric and AI/ML techniques to optimize dose selection, trial design, and regulatory submissions. Drive innovation in clinical pharmacology through cross-functional collaboration and external engagement. Operate in a science-driven environment focused on accelerating the development of novel cancer therapies.

GSK US$188,100 – US$313,500 pa

Director, AI/ML MIDD Oncology Clinical Pharmacology, Modeling and Simulation

Lead clinical pharmacology and modelling & simulation efforts for oncology drug development, applying AI/ML and quantitative methods to optimise dosing, trial design, and regulatory strategy. Drive innovation in model-informed drug development across small molecules, biologics, and antibody-drug conjugates. Collaborate with cross-functional teams to accelerate therapies to patients using advanced pharmacometric and machine learning techniques.

GSK £188,100 – £313,500 pa

VP, Medicine Development Leader- Cancer Vaccines, Oncology Research Unit

The VP, Medicine Development Leader for Cancer Vaccines will lead the global development of GSK's cancer vaccine, from early stages through approval and launch. Key responsibilities include strategic vision, team leadership, and collaboration with various stakeholders across R&D and commercial functions to ensure successful development and market entry.

GSK Stevenage, United Kingdom